Clinical Trial Update: Effect of Fructose Reduction on Non-alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome in Overweight Children [NA]

View source ↗

Summary

A clinical trial is evaluating whether reducing fructose intake affects non-alcoholic fatty liver disease and metabolic syndrome in overweight children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: University of Hohenheim | Conditions: Non-alcoholic Fatty Liver Disease | NA | Status: UNKNOWN